{"denoms":[{"counts":[{"groupId":"BG000","value":"62"}],"units":"Participants"}],"groups":[{"description":"Patients in this group signed consent, met eligibility criteria, and all had ALK-positive cancer of a primary lung lesion with systemic progression (excluding the central nervous system)","id":"BG000","title":"ALK-positive NSCLC With Progression"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"21","upperLimit":"81","value":"55"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"62"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"22"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"40"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"62"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"denoms":[{"counts":[{"groupId":"BG000","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"62"}],"units":"Participants"}],"title":"United States"}],"description":"Region of Enrollment, Study conducted in United States","paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"62"}],"units":"Participants"}]}],"paramType":"NUMBER","title":"Subjects diagnosed with Advanced ALK positive NSCLC with progression","unitOfMeasure":"participants"}]}